- Sintx Technologies (NASDAQ:SINT) -25%.
- Martin Midstream Partners (NASDAQ:MMLP) -27% on Q4 earnings.
- Spring Bank Pharmaceuticals (NASDAQ:SBPH) -26% after discontinuing development of Inarigivir.
- Armata Pharmaceuticals (NYSEMKT:ARMP) -13%.
- Biohaven Pharmaceutical Holding (NYSE:BHVN) -11% after pricing equity offering.
- Extreme Networks (NASDAQ:EXTR) -10% on Q2 earnings.
- NantHealth (NASDAQ:NH) -8%.
- YayYo (NASDAQ:YAYO) -8%.
- Xilinx (NASDAQ:XLNX) -7% on Q3 earnings.
- Youngevity International (NASDAQ:YGYI) -7%.
- Gilat Satellite Networks (NASDAQ:GILT) -6% after being acquired by Comtech Telecommunications.
- Intelsat (NYSE:I) -6% after Senate bill proposes limit to C-band payouts.
- Advanced Micro Devices (NASDAQ:AMD) -5% on Q4 earnings.